Platelet transfusion for low platelet counts in blood cancer patients
Part of Blood & lymphatic clinical trials.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer or bone marrow failure causing very low platelet counts.
- You need a platelet transfusion because of your low platelet count.
- You can recognize and report any bleeding symptoms you have.
- You agree to take part in the study.
- You are registered with the French social security system or eligible for it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This study tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent dangerous bleeding. If you're in the ICU with a very low platelet count, this trial might help decide the best way to keep you safe.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
This trial tests a new combination of two medicines (hetrombopag and rhTPO) that help raise platelet counts, which often drop during cancer treatment. The goal is to see if this approach works well and is safe for people with low platelets caused by cancer therapy.
Hear when a new Thrombocytopaenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.